Download Files:
Patritumab deruxtecan
1,272 CAD – 7,440 CADPrice range: 1,272 CAD through 7,440 CAD
Products Details
Product Description
– Patritumab deruxtecan (HER3-DXd) is an antibody-drug coupling (ADC) targeting HER3 consisting of a fully humanized anti-HER3 IgG1 monoclonal antibody linked via a cleavable tetrapeptide linker to a topoisomerase I inhibitor payload (an ezetiocan derivative, DXd) for the study of non-small cell lung cancer (NSCLC).
Web ID
– T77910
Storage Temperature
– -20℃
Shipping
– Blue Ice
CAS Number
– 2227102-46-5
Compound Purity
– 0.95
Pathway
– Antibody-drug Conjugate/ADC Related
Product type
– Inhibitory Antibodies
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
Related Products
1000 in stock
1000 in stock
1000 in stock
1000 in stock